Items where authors include "Bermejo, I."

Article

Bermejo, I. orcid.org/0000-0001-9105-8088, Squires, H. orcid.org/0000-0002-2776-4014, Poku, E.N. et al. (7 more authors) (2019) Adalimumab for non-infectious uveitis: is it cost-effective? British Journal of Ophthalmology, 103 (11). pp. 1633-1638. ISSN 0007-1161

Squires, H. orcid.org/0000-0002-2776-4014, Bermejo, I. orcid.org/0000-0001-9105-8088, Poku, E.N. et al. (7 more authors) (2019) Dexamethasone implant for non-infectious uveitis: is it cost-effective? British Journal of Ophthalmology, 103 (11). pp. 1639-1644. ISSN 0007-1161

Bermejo, I. orcid.org/0000-0001-9105-8088, Ren, S., Simpson, E. et al. (4 more authors) (2018) Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36 (12). pp. 1427-1437. ISSN 1170-7690

Uttley, L. orcid.org/0000-0003-4603-9069, Bermejo, I., Ren, S. orcid.org/0000-0003-3568-7124 et al. (5 more authors) (2018) Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 36 (9). pp. 1063-1072. ISSN 1170-7690

Ren, S. orcid.org/0000-0003-3568-7124, Bermejo, I., Simpson, E. et al. (4 more authors) (2018) Baricitinib for previously treated moderate or severe rheumatoid arthritis: an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics, 36. pp. 769-778. ISSN 1170-7690

Bermejo, I. orcid.org/0000-0001-9105-8088, Stevenson, M. orcid.org/0000-0002-3099-9877, Cooper, K. orcid.org/0000-0002-7702-8103 et al. (6 more authors) (2018) Mepolizumab for treating severe eosinophilic asthma: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics, 36. pp. 131-144. ISSN 1170-7690

Squires, H.Y. orcid.org/0000-0002-2776-4014, Poku, E., Bermejo, I. et al. (7 more authors) (2017) A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate, posterior or panuveitis in adults. Health Technology Assessment , 21 (68). ISSN 1366-5278

Bermejo, I. orcid.org/0000-0001-9105-8088, Stevenson, M., Archer, R. et al. (5 more authors) (2017) Certolizumab Pegol for Treating Rheumatoid Arthritis Following Inadequate Response to a TNF-α Inhibitor: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics, 35 (11). pp. 1141-1151. ISSN 1170-7690

Bermejo, I. orcid.org/0000-0001-9105-8088, Tappenden, P. and Youn, J.H. (2017) Replicating Health Economic Models: Firm Foundations or a House of Cards? Pharmacoeconomics, 35. pp. 1113-1121. ISSN 1170-7690

Bermejo, I., Tappenden, P. orcid.org/0000-0001-6612-2332 and Youn, J.H. (2017) Response to ‘Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”’. PharmacoEconomics, 35 (11). pp. 1189-1190. ISSN 1170-7690

Díez, F.J., Yebra, M., Bermejo, I. et al. (4 more authors) (2017) Markov Influence Diagrams. Medical Decision Making, 37 (2). pp. 183-195. ISSN 0272-989X